"10.1371_journal.pone.0103776","plos one","2014-07-31T00:00:00Z","Urs B Hagemann; Lavinia Gunnarsson; Solène Géraudie; Ulrike Scheffler; Remko A Griep; Herald Reiersen; Alexander R Duncan; Sergej M Kiprijanov","Affitech Research AS, Oslo, Norway","Conceived and designed the experiments: UBH LG SG US HR RAG ARD SMK. Performed the experiments: UBH LG SG US HR RAG. Analyzed the data: UBH LG SMK. Contributed reagents/materials/analysis tools: US RAG. Contributed to the writing of the manuscript: SMK.","UBH is co-author of a patent, describing one of the antibodies in the entitled manuscript. The patent number is: WO2012/076883. LG is co-author of a patent, describing one of the antibodies in the entitled manuscript. The patent number is: WO2010/142952. SG has no competing interests. US has no competing interests. HR is co-author of a patent, describing one of the antibodies in the entitled manuscript. The patent number is: WO2012/076883. RAG is co-author of a patent, describing one of the antibodies in the entitled manuscript. The patent number is: WO2012/076883. ARD is managing director of Actigen Limited and current CSO of Affitech. He is not the author of any patents involved in the manuscript. SMK is co-author of two patents, describing the antibodies in the entitled manuscript. The patent numbers are: WO2010/142952 and WO2012/076883. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","07","Urs B Hagemann","UBH",8,FALSE,8,6,3,NA,TRUE,TRUE,FALSE,0,NA,FALSE
